Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5162000 | 0.98 | MAPT (0.56) | CYP3A4MAPTKDM4EIDO1ALDH1A1 | |
| Ethylbenzene SCHEMBL27988415 | 0.91 | TP53 (0.58) | CYP3A4MAPTKDM4EIDO1ALDH1A1 | |
| SCHEMBL24239349 | 0.81 | AOC3 (0.52) | CYP3A4MAPTKDM4EIDO1ALDH1A1 | |
| SCHEMBL16735543 | 0.81 | IDO1 (0.50) | CYP3A4MAPTKDM4EIDO1ALDH1A1 | |
| SCHEMBL14797789 | 0.79 | CYP3A4 (0.46) | CYP3A4MAPTKDM4EIDO1ALDH1A1 | |
| SCHEMBL8215112 | 0.79 | TSHR (0.54) | CYP3A4MAPTKDM4EIDO1ALDH1A1 | |
| SCHEMBL24239386 | 0.79 | CYP3A4 (0.52) | CYP3A4MAPTKDM4EIDO1ALDH1A1 | |
| SCHEMBL8854666 | 0.78 | CYP3A4 (0.50) | CYP3A4MAPTKDM4EIDO1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL607788 | 0.78 | ALDH1A1 (0.52) | CYP3A4MAPTKDM4EIDO1ALDH1A1 | |
| Trimethylammonium SCHEMBL27861478 | 0.77 | MEN1 (0.64) | CYP3A4MAPTKDM4EIDO1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 505 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115895324-B | Stone-strike resistant electrophoretic paint | 浩力森化学科技（江苏）有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-115895324-A | Stone-impact-resistant electrophoretic coating | 浩力森化学科技（江苏）有限公司 | 2023-04-04 | — | — | CN | claimed |
| US-20220118086-A1 | INTEGRIN AGONISTS OR ACTIVATING COMPOUNDS AND METHODS FOR MAKING AND USING SAME | 7 Hills Pharma LLC (US) | 2022-04-21 | — | — | US | claimed |
| CN-107216704-A | A kind of cathodic electrodeposition paint emulsion and preparation method thereof | 枣阳市同邦达科技有限公司 | 2017-09-29 | — | — | CN | claimed |
| CN-101941982-B | Novel preparation method of pharmaceutical ceforanide | SICHUAN IND INST ANTIBIOTICS CHINA NAT PHARMACEUTICAL GROUP CORP | 2012-03-14 | — | — | CN | claimed |
| CN-101941982-A | Novel preparation method of pharmaceutical ceforanide | SICHUAN IND INST ANTIBIOTICS CHINA NAT PHARMACEUTICAL GROUP CORP | 2011-01-12 | — | — | CN | claimed |
| CN-101821238-A | Suppress the active isophthaloyl sulfonamide derivatives of beta-secretase (BETA-SECRETASE) | COMENTIS INC | 2010-09-01 | — | — | CN | claimed |
| EP-1155001-A4 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | LION BIOSCIENCE AG (DE) | 2003-05-28 | — | — | EP | claimed |
| EP-1155001-A1 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 2001-11-21 | — | — | EP | claimed |
| WO-2000050406-A1 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | LION BIOSCIENCE AG (DE) | 2000-08-31 | — | — | WO | claimed |
| US-4748083-A | EPISULFIDE, HYDROCARBYLENEDIKETIMINE | SIKA AG, VORM. KASPAR WINKLER & CO. (CH) | 1988-05-31 | — | — | US | claimed |
| WO-2025124547-A1 | CATHODE ELECTROPHORETIC COATING HAVING HIGH CORROSION RESISTANCE, AND PREPARATION METHOD THEREFOR | 浩力森化学科技（江苏）有限公司 | 2025-06-19 | — | — | WO | disclosed |
| EP-4518842-A1 | NOVEL LIPID-BASED SMALL MOLECULE INTEGRIN RECEPTOR-LIGAND AGONIST ADJUVANTS CARRIER COMPOSITIONS, INTEGRIN AGONIST ADJUVANT PHARMACEUTICAL COMPOSITIONS THEREFROM, AND METHODS FOR MAKING AND USING SAME | 7 Hills Pharma Inc. (US) | 2025-03-12 | — | — | EP | disclosed |
| CN-119546288-A | Novel lipid-based small molecule integrin receptor-ligand agonist adjuvant carrier compositions, integrin agonist adjuvant pharmaceutical compositions thereof, and methods of making and using the same | 7山药物公司 | 2025-02-28 | — | — | CN | disclosed |
| US-12109263-B2 | Integrin agonists or activating compounds and methods for making and using same | 7 HILLS PHARMA INC. | 2024-10-08 | — | — | US | disclosed |
| US-4421897-A | ADHESIVES, COATINGS, MOLDING MATERIALS | CIBA-GEIGY CORPORATION (US) | 1983-12-20 | — | — | US | disclosed |
| EP-0018950-B1 | CRYSTALLINE EPOXY RESIN BASED ONE COMPONENT SYSTEMS AND THEIR APPLICATION | CIBA-GEIGY AG (CH) | 1983-07-13 | — | — | EP | disclosed |
| US-4339571-A | DIGLYCIDYL ISOPHTHALATE, OR TEREPHTHALATE | CIBA-GEIGY CORPORATION (US) | 1982-07-13 | — | — | US | disclosed |
| EP-0018950-A1 | Crystalline epoxy resin based one component systems and their application | CIBA-GEIGY AG (CH) | 1980-11-12 | — | — | EP | disclosed |
| US-4063546-A | Heat store and installation for the utilization of solar energy | CIBA-GEIGY CORPORATION (US) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220118086-A1 | INTEGRIN AGONISTS OR ACTIVATING COMPOUNDS AND METHODS FOR MAKING AND USING SAME | ICOS, CD47, CD274 | CYP3A4 3751/4885MAPT 3950/4885KDM4E 1595/4885 |
| US-12109263-B2 | Integrin agonists or activating compounds and methods for making and using same | ICOS, CD47, CD274 | CYP3A4 3751/4885MAPT 3950/4885KDM4E 1595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.